Böbrek yetmezliği olgularında adale gevşeticilerin etkileri
Başlık çevirisi mevcut değil.
- Tez No: 32691
- Danışmanlar: Belirtilmemiş.
- Tez Türü: Tıpta Uzmanlık
- Konular: Üroloji, Urology
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 1994
- Dil: Türkçe
- Üniversite: GATA
- Enstitü: Tıp Fakültesi
- Ana Bilim Dalı: Anesteziyoloji ve Reanimasyon Ana Bilim Dalı
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: 54
Özet
SUMMARY It has been an important problem for anesthesiologists to be unable to determine the duration of action of neuromus cular blocking drugs used in the anesthesia of patients with renal failure. Neuromusculary blockades in patients with renal failure supplied by different blocking drugs leading to the postoperative period have frequently been reported. Today, neuromuscular blocking drugs atracurium besilate and vecuronium bromid, are accepted to be the drugs of choice to be used safely in cases with renal failure. In our study, we aimed to compare the duration of action of these two drugs both in normal and in patients with renal failure by using a peripheral nerve stimulator. Our findings showed that the duration of action of atracurium besilate didn't change in cases with renal failure. But the duration of action of vecuronium bromid increased with the doses following the 4th maintenance administration in patients with renal failure when compared with the normal cases. As a result, atracurium besilate is safer in cases with renal failure. But, a more potent neuromuscular blocking drug, vecuronium bromid, can be used safely when the neuro musculary function is monitorized. 42
Özet (Çeviri)
SUMMARY It has been an important problem for anesthesiologists to be unable to determine the duration of action of neuromus cular blocking drugs used in the anesthesia of patients with renal failure. Neuromusculary blockades in patients with renal failure supplied by different blocking drugs leading to the postoperative period have frequently been reported. Today, neuromuscular blocking drugs atracurium besilate and vecuronium bromid, are accepted to be the drugs of choice to be used safely in cases with renal failure. In our study, we aimed to compare the duration of action of these two drugs both in normal and in patients with renal failure by using a peripheral nerve stimulator. Our findings showed that the duration of action of atracurium besilate didn't change in cases with renal failure. But the duration of action of vecuronium bromid increased with the doses following the 4th maintenance administration in patients with renal failure when compared with the normal cases. As a result, atracurium besilate is safer in cases with renal failure. But, a more potent neuromuscular blocking drug, vecuronium bromid, can be used safely when the neuro musculary function is monitorized. 42
Benzer Tezler
- Zehirlenme olgularında rabdomyolizin ölüm mekanizmasındaki rolü
Role of rhabdomyolysis on mechanism of death in cases of intoxication
PINAR BAKIR KÜÇÜK
- Dokuz Eylül Üniversitesi Hastanesi nefroloji kliniğinde takip edilen erişkin birincil membranöz glomerülonefritli hastalarda klasik prognoz kriterlerinin değerlendirilmesi
Evaluation of classical prognosis criteria in patients with primary membranous glomerulonephritis in nephrology clinic of Dokuz Eylul University Hospital
ERHAN ADALI
Tıpta Uzmanlık
Türkçe
2018
NefrolojiDokuz Eylül Üniversitesiİç Hastalıkları Ana Bilim Dalı
PROF. DR. CANER ÇAVDAR
- Akut lenfoblastik lösemili çocuklarda kemoterapiye bağlı gelişen akut toksisitenin değerlendirilmesi
Chemotherapy related acute side effects in children treated for Acute Lymphoblastic Leukemia
FATİH DEMİRTAŞ
Tıpta Uzmanlık
Türkçe
2011
Çocuk Sağlığı ve HastalıklarıUludağ ÜniversitesiÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
PROF. DR. ADALET MERAL GÜNEŞ
- Kronik böbrek yetmezliği olgularında retina damar yoğunluğu ve sinir lifi kalınlığının incelenmesi
Kronik böbrek yetmezliği olgularinda retina damar yoğunluğu ve sinir lifi kalinliğinin i̇ncelenmesi
ÖZLEM ERGÜN
Tıpta Uzmanlık
Türkçe
2020
Göz HastalıklarıSağlık Bilimleri ÜniversitesiGöz Hastalıkları Ana Bilim Dalı
DOÇ. DR. FADIME ULVIYE YIGIT